tirzepatide slows gastric emptying A 32-year-old man developed gastroparesis after taking for weight loss, which isn't approved in India. Doctors advise against using it without medical supervision Avoid Gastroparesis on Tirzepatide: Safe

Whether you are a super responder or a steady loser, the goal remains the same: a healthier metabolic baseline

Getting emotional support if weaning feels sudden, unwanted, or complicated

Spatial Metabolomics Reveals How Tirzepatide Inhibits Colorectal Cancer via Glucose Metabolic Reprogramming We are excited to share a recent publication in Advanced Science titled The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism. In this study, the authors employed spatial metabolomics services provided by MetwareBio to explore the metabolic mechanisms by which tirzepatide (TZP)a dual GIP and GLP-1 receptor agonist initially approved for type 2 diabetesexerts potent anti-tumor effects in colorectal cancer (CRC)

Acute kidney injury is when the kidneys suddenly stop functioning properly

GHK-Cu acts on matrix regeneration (collagen, elastin, over 4000 genes)